Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemia

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
Haematologica Early view Mar 5, 2026 https://doi.org/10.3324/haematol.2025.300442

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.300442
 
Published
2026-03-05
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

No Data Yet

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online